Tag Archives: albert bourla

Pfizer says COVID-19 vaccine is 90% effective in phase 3 trial

Protection in patients was achieved seven days after the second of two doses and 28 days after the first, according to preliminary findings. A vaccine developed jointly by Pfizer and BioNTech was 90% effective in preventing Covid-19 infections in ongoing phase 3 trials, the companies announced Monday. Protection in patients …

Read More »